cdmo.directory
← Compare landing

Cell Therapies vs Pluri

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/celltherapies/pluri-biotech

CategoryCell TherapiesPluri
Listed sitecdmocdmo
SummaryGMP contract manufacturer of autologous and allogeneic cell therapies from first-in-human trials through commercial supply, with two decades of experience in CAR-T, mesenchymal stromal cells, TILs, and pluripotent stem cell derivatives. Offers end-to-end cold chain management, process development, quality control analytics, and regulatory consulting across Australia and Asia-Pacific.Full-service CDMO specializing in cell therapy manufacturing with GMP facilities, proprietary packed-bed expansion technology, and regulatory approvals from FDA, EMA, PMDA, and other key agencies for clinical-stage production.
Services
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Technology Transfer
  • Process Development
  • CMC Analytical Development
  • Quality Control Testing
  • Cold-Chain Storage & Logistics
  • CMC Regulatory Submission Support
  • Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Cell-Line Development
  • Process Development
  • CMC Analytical Development
  • Formulation Development
  • Technology Transfer
  • Cold-Chain Storage & Logistics
  • Autologous Cell Therapy Manufacturing
  • CMC Regulatory Submission Support
  • Sterile Fill-Finish & Aseptic Manufacturing
Modalities
  • Cell Therapy
  • Gene Therapy
  • Cell Therapy
Indications
  • Oncology
Data not yet provided.
Locations
  • Headquarters / Manufacturing & Development, Melbourne, Victoria, Australia
  • Headquarters, Haifa, Haifa, Israel
  • USA Office, USA
Certifications
  • TGA · Identifier: TGA-licensed
  • FDA · Identifier: FDA inspection-ready
  • PMDA · Identifier: PMDA inspection-ready
  • EMA · Identifier: EMA inspection-ready
  • FDA · Identifier: U.S. Food and Drug Administration
  • EMA · Identifier: European Medicines Agency
  • PMDA · Identifier: Japan's Pharmaceuticals and Medical Devices Agency
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.